BioSpace News Archive

Business

Tabula Rasa Healthcare to Announce Third Quarter 2019 Operating Results and Host Conference Call on Thursday, November 7, 2019

A conference call hosted by Chairman and CEO, Calvin H. Knowlton, Ph.D., President and Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD, MBA, and Chief Financial Officer, Brian W. Adams will follow at 5:00 p.m. ET.

October 24, 2019
·
1 min read
BioCapital

Statement from Acting FDA Commissioneron the agency’s efforts to protect patients from potentially harmful drugs sold as homeopathic products

FDA uses a risk-based approach to monitor these products and to evaluate reports of adverse effects.

October 24, 2019
·
5 min read
Lilly Announces Cash Tender Offer for Up to $2.0 Billion Aggregate Principal Amount of Its Outstanding Debt Securities

Eli Lilly and Company (NYSE: LLY) announced today that it has commenced a cash tender offer for up to $2.0 billion aggregate principal amount (the “tender cap”) of specified series of its outstanding debt.

October 24, 2019
·
11 min read
Business

Prime Therapeutics’ Omaha Branch Moves into Inviting New Space

Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 28 million members nationally, is moving its Omaha, Neb. office to a newly renovated facility less than a block from its previous office.

October 24, 2019
·
2 min read
Business

Lupus Research Alliance Announces 2019 Distinguished Innovator Awards Aimed at New Lupus Treatments

The Lupus Research Alliance proudly announces two exceptional recipients of the 2019 Dr. William E. Paul Distinguished Innovator Award in Lupus and Autoimmunity: Fabienne Mackay, PhD, and Jeffrey Rathmell, PhD.

October 24, 2019
·
2 min read
Horizon Therapeutics plc Named One of the Most Innovative Companies by Crain’s Chicago Business

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it is has been named one of the Most Innovative Companies in Chicago by Crain’s Chicago Business, ranking number two

October 24, 2019
·
2 min read
Business

Thomas Lehner, PhD, MPH, Joins the New York Genome Center as Scientific Director of Neuropsychiatric Disease Genomics

The New York Genome Center (NYGC) is pleased to announce the appointment of Thomas Lehner, PhD, MPH, as its Scientific Director of Neuropsychiatric Disease Genomics

October 24, 2019
·
4 min read
Deals

Nordic Nanovector ASA: Mandatory Notification of Trade - Primary Insider - Oct. 24, 2019

Tone Kvåle, CFO, has purchased 5,000 shares in Nordic Nanovector ASA at an average share price of NOK 19.96 per share.

October 24, 2019
·
1 min read
Genkyotex Provides Business Update and Reports Cash Position at September 30, 2019

Genkyotex (Euronext Paris & Brussels: FR0013399474 – GKTX), a biopharmaceutical company and the leader in NOX therapies, announced today cash and cash equivalents of €3.1 million as of September 30, 2019

October 24, 2019
·
6 min read
Job Trends

UCLA Study Links Healthwise® Shared Decision Making Tools to Better Clinical Outcomes in Diabetes PatientsResearch shows that people who use Healthwise SDM tools are significantly more engaged patients.

A study conducted by physicians and public health experts at UCLA and surrounding health agencies tested the efficacy of shared decision making tools to improve diabetes prevention in over 350 prediabetes patients across 20 primary care clinics.

October 24, 2019
·
3 min read